secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROCEPT BioRobotics Corp (PRCT)
CIK:        0001588978
Form:       8-K
Filed at:   2024-08-01T23:59:59+00:00
Accession:  0001588978-24-000018
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PROCEPT BioRobotics Q2 revenue $53.4M (+61% YoY); raises FY2024 revenue and EBITDA guidance
--------------------------------------------------------------------------------

- Total revenue $53.4M (+61% YoY); U.S. handpiece & consumables $27.3M (+101% YoY).
- Net loss $25.6M; Adjusted EBITDA loss $18.0M improved from $19.9M loss in prior period.
- Raised FY2024 revenue guidance to ~$217M (from $213.5M); EBITDA loss guidance narrowed to $67.5M from $70M.
- Gross margin reached 59% (vs 56% YoY); cash & investments $214.1M; Q2 cash usage $11.5M vs $31.6M in Q1.
- Sold 47 U.S. robotic systems in Q2; U.S. install base 400; international revenue $5.7M (+79% YoY).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1588978/000158897824000018/0001588978-24-000018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1588978/000158897824000018/prct-20240801.htm
  HTML page:      https://secwatch.observer/filing/0001588978-24-000018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer